These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30352632)

  • 1. Frequency of atrial thrombus formation in patients with atrial fibrillation under treatment with non-vitamin K oral anticoagulants in comparison to vitamin K antagonists: a systematic review and meta-analysis.
    Reers S; Karanatsios G; Borowski M; Kellner M; Reppel M; Waltenberger J
    Eur J Med Res; 2018 Oct; 23(1):49. PubMed ID: 30352632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Risk of Gastrointestinal Bleeding between Non-Vitamin K Antagonist Oral Anticoagulants and Vitamin K Antagonists in the Asian Atrial Fibrillation Patients: A Meta-Analysis.
    Yang KT; Sun WC; Tsai TJ; Tsay FW; Chen WC; Cheng JS
    Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33375495
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of left atrial abnormalities under treatment with dabigatran, rivaroxaban, and vitamin K antagonists.
    Reers S; Agdirlioglu T; Kellner M; Borowski M; Thiele H; Waltenberger J; Reppel M
    Eur J Med Res; 2016 Oct; 21(1):41. PubMed ID: 27769294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of transesophageal echocardiography findings after different anticoagulation strategies in patients with atrial fibrillation: a systematic review and meta-analysis.
    Yang J; Zhang X; Wang XY; Zhang C; Chen SZ; Hu SJ
    BMC Cardiovasc Disord; 2019 Nov; 19(1):261. PubMed ID: 31771529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Efficacy of Non-Vitamin K Antagonist Oral Anticoagulants in the Prevention of Left Atrial Thrombus in Patients With Atrial Fibrillation Compared With Vitamin K Antagonists: A Meta-Analysis.
    Liu J; Wu Y; Li S; Song L; Hu C
    Heart Surg Forum; 2020 Oct; 23(6):E733-E739. PubMed ID: 33234210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left atrial appendage thrombus in patients with atrial fibrillation who underwent oral anticoagulation.
    Karwowski J; Rekosz J; Mączyńska-Mazuruk R; Wiktorska A; Wrzosek K; Loska W; Szmarowska K; Solecki M; Sumińska-Syska J; Dłużniewski M
    Cardiol J; 2024; 31(3):461-471. PubMed ID: 35703043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta-analysis.
    Ge Z; Faggioni M; Baber U; Sartori S; Sorrentino S; Farhan S; Chandrasekhar J; Vogel B; Qadeer A; Halperin J; Reddy V; Dukkipati S; Dangas G; Mehran R
    Cardiovasc Ther; 2018 Oct; 36(5):e12457. PubMed ID: 29971964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel anticoagulants versus vitamin K antagonists for cardioversion of non- valvular atrial fibrillation - a meta-analysis of more than 17000 patients.
    Mincu RI; Mahabadi AA; Totzeck M; Rassaf T
    Sci Rep; 2019 Feb; 9(1):3011. PubMed ID: 30816247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K and non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life.
    Giustozzi M; Vedovati MC; Verdecchia P; Pierpaoli L; Verso M; Conti S; Cianella F; Marchesini E; Filippucci E; Agnelli G; Becattini C
    Eur J Intern Med; 2016 Sep; 33():42-6. PubMed ID: 27394924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and predictors of left atrial thrombosis in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants.
    Angelini F; Bocchino PP; Peyracchia M; Saglietto A; Magnano M; Patanè N; D'Ascenzo F; Giustetto C; Anselmino M; Gaita F; Toso E
    Acta Cardiol; 2023 May; 78(3):290-297. PubMed ID: 34821203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Number needed to treat based on real-world evidence for non-vitamin K antagonist oral anticoagulants versus vitamin K antagonist oral anticoagulants in stroke prevention in patients with non-valvular atrial fibrillation.
    Briere JB; Bowrin K; Millier A; Toumi M; Wojciechowski P; Taieb V
    J Med Econ; 2019 Aug; 22(8):760-765. PubMed ID: 30969801
    [No Abstract]   [Full Text] [Related]  

  • 13. Differences in knowledge among patients with atrial fibrillation receiving non-vitamin K antagonist oral anticoagulants and vitamin K antagonists.
    Konieczyńska M; Sobieraj E; Bryk AH; Dębski M; Polak M; Podolec P; Małecka B; Pająk A; Desteghe L; Heidbuchel H; Undas A
    Kardiol Pol; 2018; 76(7):1089-1096. PubMed ID: 29528483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world.
    Bertaglia E; Anselmino M; Zorzi A; Russo V; Toso E; Peruzza F; Rapacciuolo A; Migliore F; Gaita F; Cucchini U; De Divitiis M; Iliceto S; Stabile G
    Int J Cardiol; 2017 Dec; 249():179-183. PubMed ID: 29121724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial Thrombosis Prevalence Before Cardioversion or Catheter Ablation of Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis of Direct Oral Anticoagulants Versus Vitamin K Antagonists.
    Troisi F; Guida P; Vitulano N; Quadrini F; Di Monaco A; Patti G; Grimaldi M
    Am J Cardiol; 2024 May; 218():77-85. PubMed ID: 38458580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis.
    Santarpia G; De Rosa S; Polimeni A; Giampà S; Micieli M; Curcio A; Indolfi C
    PLoS One; 2015; 10(5):e0126512. PubMed ID: 25974377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-vitamin K oral anticoagulants versus warfarin for left atrial appendage thrombus resolution in nonvalvular atrial fibrillation or flutter.
    Hussain A; Katz WE; Genuardi MV; Bhonsale A; Jain SK; Kancharla K; Saba S; Shalaby AA; Voigt AH; Wang NC
    Pacing Clin Electrophysiol; 2019 Sep; 42(9):1183-1190. PubMed ID: 31355470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.
    De Caterina R; Brüggenjürgen B; Darius H; Köhler S; Lucerna M; Pecen L; Renda G; Schilling RJ; Schliephacke T; Zamorano JL; Le Heuzey JY; Kirchhof P
    Arch Cardiovasc Dis; 2018 Feb; 111(2):74-84. PubMed ID: 28942115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of non-vitamin K antagonist oral anticoagulants on left atrial or atrial appendage thrombi in patients with nonvalvular atrial fibrillation].
    Cui J; Du X; Wu JH; Jia CQ; Li X; Ning M; Lyu J; Yang Y; Liu XH; Dong JZ; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Aug; 46(8):606-610. PubMed ID: 30139010
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-vitamin K oral anticoagulants and risk of fractures: a systematic review and meta-analysis.
    Mongkhon P; Fanning L; Wong KHTW; Man KKC; Wong ICK; Lau WCY
    Europace; 2021 Jan; 23(1):39-48. PubMed ID: 33085751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.